The forecasted data for trachea, bronchus, or lung malignant neoplasms mortality among females in the UK shows a gradual decline from 15.38 thousand deaths in 2024 to 14.89 thousand deaths in 2028. This represents a steady year-on-year decrease in mortality rates: -0.78% between 2024 and 2025, -0.85% from 2025 to 2026, -0.79% from 2026 to 2027, and -0.80% from 2027 to 2028. Compared to 2023, when deaths were at 15.52 thousand, the 5-year compound annual growth rate showed an average annual decline of approximately -1.04%.

Future trends to watch for:

Medical advancements could further accelerate the decline in mortality rates.
Smoking cessation efforts and air quality improvements may continue to positively impact death rates.
Ongoing monitoring of demographic changes and healthcare access disparities will be critical.